{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:24:03Z","timestamp":1782523443277,"version":"3.54.5"},"reference-count":45,"publisher":"Impact Journals, LLC","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,25]]},"DOI":"10.18632\/oncotarget.17534","type":"journal-article","created":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T10:32:16Z","timestamp":1493548336000},"page":"49253-49263","source":"Crossref","is-referenced-by-count":17,"title":["Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K\/NFKB\/MAPK activation"],"prefix":"10.18632","volume":"8","author":[{"given":"Julia","family":"Templin","sequence":"first","affiliation":[{"name":"Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djordje","family":"Atanackovic","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hasche","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabarinath Venniyil","family":"Radhakrishnan","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Luetkens","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,4,28]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Russell","year":"2014","journal-title":"Leukemia"},{"key":"2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.hoc.2007.08.007","article-title":"The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies","volume":"21","author":"Anderson","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"3","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V93.5.1658","article-title":"Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines","volume":"93","author":"Dalton","year":"1999","journal-title":"Blood"},{"key":"4","first-page":"3876","article-title":"Cytokines modulate telomerase activity in a human multiple myeloma cell line","volume":"62","author":"Anderson","year":"2002","journal-title":"Cancer Res"},{"key":"5","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1038\/sj.onc.1207458","article-title":"Blockade of ubiquitin-conjugating enzyme CDC34 enhances anti-myeloma activity of Bortezomib\/Proteasome inhibitor PS-341","volume":"23","author":"Anderson","year":"2004","journal-title":"Oncogene"},{"key":"6","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1182\/blood-2005-08-3434","article-title":"Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells","volume":"107","author":"Anderson","year":"2006","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1158\/1078-0432.CCR-12-3676","article-title":"Accessory cells of the microenvironment protect multiple myeloma from T-cell cytotoxicity through cell adhesion-mediated immune resistance","volume":"19","author":"Mitsiades","year":"2013","journal-title":"Clin Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1038\/sj.onc.1209456","article-title":"Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma","volume":"25","author":"Vacca","year":"2006","journal-title":"Oncogene"},{"key":"9","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1038\/sj.leu.2403970","article-title":"Growth factors and antiapoptotic signaling pathways in multiple myeloma","volume":"19","author":"Bloem","year":"2005","journal-title":"Leukemia"},{"key":"10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.exphem.2010.06.012","article-title":"The cytokine\/chemokine pattern in the bone marrow environment of multiple myeloma patients","volume":"38","author":"Atanackovic","year":"2010","journal-title":"Exp Hematol"},{"key":"11","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/sj.leu.2402295","article-title":"Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications","volume":"15","author":"Ralph","year":"2001","journal-title":"Leukemia"},{"key":"12","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.V85.7.1903.bloodjournal8571903","article-title":"CD40 ligand triggered interleukin-6 secretion in multiple myeloma","volume":"85","author":"Anderson","year":"1995","journal-title":"Blood"},{"key":"13","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/0008-5472.CAN-03-3630","article-title":"Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: clinical implications","volume":"64","author":"Munshi","year":"2004","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF02983377","article-title":"Survival and proliferation factors of normal and malignant plasma cells","volume":"78","author":"Rossi","year":"2003","journal-title":"Int J Hematol"},{"key":"15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jnci\/djs257","article-title":"Role of interleukin 16 in multiple myeloma","volume":"104","author":"Marx","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"16","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.162.3.1287","article-title":"Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent","volume":"162","author":"Cruikshank","year":"1999","journal-title":"J Immunol"},{"key":"17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2567.2000.00959.x","article-title":"Human B-cell lines constitutively express and secrete interleukin-16","volume":"99","author":"Vail","year":"2000","journal-title":"Immunology"},{"key":"18","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.4049\/jimmunol.172.12.7721","article-title":"IL-16 is constitutively present in peripheral blood monocytes and spontaneously released during apoptosis","volume":"172","author":"Wewers","year":"2004","journal-title":"J Immunol"},{"key":"19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jlb.67.6.757","article-title":"Interleukin-16","volume":"67","author":"Center","year":"2000","journal-title":"J Leukoc Biol"},{"key":"20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0753-3322(00)00023-8","article-title":"The serum levels of IL-12 and IL-16 in cancer patients. Relation to the tumour stage and previous therapy","volume":"55","author":"Kovacs","year":"2001","journal-title":"Biomed Pharmacother"},{"key":"21","first-page":"295","article-title":"The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer","volume":"30","author":"Zhang","year":"2009","journal-title":"Carcinogenesis"},{"key":"22","doi-asserted-by":"crossref","first-page":"14252","DOI":"10.1073\/pnas.1103125108","article-title":"Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases","volume":"108","author":"Borrebaeck","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"23","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/pros.21197","article-title":"Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy","volume":"70","author":"Cussenot","year":"2010","journal-title":"Prostate"},{"key":"24","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/10428190701268767","article-title":"Serum levels of interleukin-16 in lymphoid malignancies","volume":"48","author":"Musolino","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ajh.10444","article-title":"Serum level of interleukin-16 in multiple myeloma patients and its relationship to disease activity","volume":"75","author":"Castanas","year":"2004","journal-title":"Am J Hematol"},{"key":"26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0145-2126(01)00192-8","article-title":"Relationship between CD4(+)\/CD8(+) T cell ratio and T cell activation in multiple myeloma: reference to IL-16","volume":"26","author":"Oshimi","year":"2002","journal-title":"Leuk Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-4632.2010.04321.x","article-title":"Serum levels of interleukin-16 in a multiple myeloma patient with cutaneous involvement","volume":"49","author":"Musolino","year":"2010","journal-title":"Int J Dermatol"},{"key":"28","doi-asserted-by":"crossref","first-page":"34970","DOI":"10.1074\/jbc.273.52.34970","article-title":"Generation of destabilized green fluorescent protein as a transcription reporter","volume":"273","author":"Kain","year":"1998","journal-title":"J Biol Chem"},{"key":"29","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1073\/pnas.96.4.1541","article-title":"GA-binding protein factors, in concert with the coactivator CREB binding protein\/p300, control the induction of the interleukin 16 promoter in T lymphocytes","volume":"96","author":"Kurth","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"30","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1100\/tsw.2006.236","article-title":"New frontiers in the treatment of multiple myeloma","volume":"6","author":"Anderson","year":"2006","journal-title":"ScientificWorldJournal"},{"key":"31","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3748\/wjg.v20.i8.1986","article-title":"Clock genes: their role in colorectal cancer","volume":"20","author":"Gazouli","year":"2014","journal-title":"World J Gastroenterol"},{"key":"32","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.4049\/jimmunol.172.3.1654","article-title":"Nuclear pro-IL-16 regulation of T cell proliferation: p27(KIP1)-dependent G0\/G1 arrest mediated by inhibition of Skp2 transcription","volume":"172","author":"Zhang","year":"2004","journal-title":"J Immunol"},{"key":"33","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00432-011-1017-x","article-title":"Introduction of pro-interleukin-16 inhibits T-lymphoblastic leukemia growth in mice","volume":"137","author":"Cruikshank","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"34","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.exphem.2007.06.016","article-title":"Characterization of in vitro growth of multiple myeloma cells","volume":"35","author":"Engelhardt","year":"2007","journal-title":"Exp Hematol"},{"key":"35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pharmthera.2012.09.001","article-title":"Immediate early response genes and cell transformation","volume":"137","author":"Davie","year":"2013","journal-title":"Pharmacol Ther"},{"key":"36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jbior.2016.05.001","article-title":"Gene regulation in the immediate-early response process","volume":"62","author":"Drablos","year":"2016","journal-title":"Adv Biol Regul"},{"key":"37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/311433a0","article-title":"Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene","volume":"311","author":"Ziff","year":"1984","journal-title":"Nature"},{"key":"38","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/blood.V88.7.2699.bloodjournal8872699","article-title":"Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial","volume":"88","author":"Van Ness","year":"1996","journal-title":"Blood"},{"key":"39","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/blood-2010-05-284422","article-title":"Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival","volume":"117","author":"Bargou","year":"2011","journal-title":"Blood"},{"key":"40","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1182\/blood.V98.9.2853","article-title":"The AKT kinase is activated in multiple myeloma tumor cells","volume":"98","author":"Lichtenstein","year":"2001","journal-title":"Blood"},{"key":"41","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1038\/sj.onc.1205923","article-title":"Role of the phosphatidylinositol 3-kinase\/Akt and mTOR\/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma","volume":"21","author":"Bouscary","year":"2002","journal-title":"Oncogene"},{"key":"42","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/leu.2008.142","article-title":"Clinical and biological significance of RAS mutations in multiple myeloma","volume":"22","author":"Fonseca","year":"2008","journal-title":"Leukemia"},{"key":"43","doi-asserted-by":"publisher","first-page":"81926","DOI":"10.18632\/oncotarget.10745","article-title":"Kinase inhibitors as potential agents in the treatment of multiple myeloma","volume":"7","author":"Abramson","year":"2016","journal-title":"Oncotarget"},{"key":"44","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.4049\/jimmunol.161.5.2248","article-title":"Maturation of B cell precursors is impaired in thymic-deprived nude and old mice","volume":"161","author":"Weksler","year":"1998","journal-title":"J Immunol"},{"key":"45","doi-asserted-by":"crossref","first-page":"W305","DOI":"10.1093\/nar\/gkp427","article-title":"ToppGene Suite for gene list enrichment analysis and candidate gene prioritization","volume":"37","author":"Jegga","year":"2009","journal-title":"Nucleic Acids Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T10:32:00Z","timestamp":1692786720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,28]]},"references-count":45,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2017,7,25]]}},"alternative-id":["17534","28512269"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17534","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,28]]}}}